PolyPhotonix Secures Multimillion Pound US Investment and Strategic Alliance for Sight Saving Mask
Prevail Partners, LLC, an affiliate of InfoWorks, has agreed to invest significantly in PolyPhotonix upon the commencement of the FDA clinical trial as lead investor in a $10M Series A investment round. Successful completion of the FDA clinical trial will open the US market to the treatment.